Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Encounter tool improves shared decision-making in stroke prevention for AF
A shared decision-making encounter tool improved measures of quality including communication and knowledge in patients with nonvalvular atrial fibrillation considering anticoagulant treatment for stroke prevention, researchers reported.
ASCLEPIOS trials: Ofatumumab reduces relapse rates in MS
Among patients with multiple sclerosis, ofatumumab was associated with lower annualized relapse rates than teriflunomide, according to a pair of phase 3 randomized controlled trials published in The New England Journal of Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
ACC: Cardiologists can use novel therapies to lower CV risk in type 2 diabetes
Cardiologists can use SGLT2 inhibitors and GLP-1 receptor agonists to help reduce risk for major adverse CV events in patients with type 2 diabetes, according to an expert consensus decision pathway from the American College of Cardiology.
Benefits of drug pricing executive orders unclear, expert says
President Donald J. Trump recently signed four executive orders aimed at lowering prescription drug prices for Americans.
SGLT2 inhibitor may cause statin toxicity
Canagliflozin, an SGLT2 inhibitor, may lead to rosuvastatin toxicity when they are prescribed together, according to a case report published in the Annals of Internal Medicine.
CGRP monoclonal antibodies reduce headaches in older patients
Calcitonin gene-related peptide, or CGRP, monoclonal antibodies reduced headache frequency among a small cohort of older adults with migraine, data show.
FDA approves cannabis product to treat seizures related to tuberous sclerosis complex
The FDA recently announced its approval of the cannabis-based Epidiolex, an oral solution to treat seizures in patients aged older than 1 year with tuberous sclerosis complex, a rare genetic disease that causes noncancerous tumors to grow in the brain and other parts of the body.
Q&A: Canadian trial evaluates real-world use of medical cannabis products
A clinical trial recently launched in Canada is the first of its kind to collect real-world data on the use of validated medical cannabis products.
AMA: Opioid prescriptions down, illicit drug use up
Although opioid prescriptions decreased in the last year, the use and overdose rates of illicit drugs — including fentanyl and stimulants — have increased, according to a progress report released by the AMA Opioid Task Force.
Mayo Clinic again named best hospital in US
Mayo Clinic has been ranked the No. 1 hospital nationwide by U.S. News and World Report, the fifth consecutive year that the hospital in Rochester, Minn., has received the top spot on the publication’s Best Hospitals Honor Roll list.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read